Xybion Digital Inc
TSXV:XYBN

  • LAST PRICE
    0.4500
  • TODAY'S CHANGE (%)
    0.0000 (0.0000%)
  • Bid / Lots
    0.4500/ 9
  • Ask / Lots
    0.4900/ 81
  • Open / Previous Close
    0.0000 / 0.4500
  • Day Range
    ---
  • 52 Week Range
    0.3200
    1.3500
  • Volume
    ---

Search Criteria

Click on magnifying glass icon to search

CompanyCountrySymbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

  • Apr 16, 2024

      Show headlines and story abstract

    • 9:03AM ET on Tuesday Apr 16, 2024 by Accesswire
      Companies Mentioned: XYBN

      Xybion's Preclinical LIMS Unifies and Enhances Laboratory Efficiency and Data Integrity for EnvolBio's CRO operations.

      PRINCETON, NJ / ACCESSWIRE / April 15, 2024 / Xybion Digital announced today its partnership with EnvolBio to digitize lab operations for end-to-end non-clinical process standardization, streamline data for faster lab operation, manage quality, improve data integrity and compliance. This end-to-end preclinical gold standard solution helps the R&D teams with the ability to seamlessly perform study planning, cost management, protocol creation, study execution, data management, reporting, and regulatory submissions of non-clinical research and development studies.

    • 9:03AM ET on Tuesday Apr 16, 2024 by Dow Jones
      Companies Mentioned: XYBN

      Xybion's Preclinical LIMS Unifies and Enhances Laboratory Efficiency and Data Integrity for EnvolBio's CRO operations.

      PRINCETON, NJ / ACCESSWIRE / April 15, 2024 / Xybion Digital announced today its partnership with EnvolBio to digitize lab operations for end-to-end non-clinical process standardization, streamline data for faster lab operation, manage quality, improve data integrity and compliance. This end-to-end preclinical gold standard solution helps the R&D teams with the ability to seamlessly perform study planning, cost management, protocol creation, study execution, data management, reporting, and regulatory submissions of non-clinical research and development studies.

Peers Headlines